Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opioid-Limited Pain Control in Colorectal Surgery (ERAS Protocol)
NCT02958566Phase 4Unknown
- Sponsor
- University of Illinois College of Medicine Peoria
- Start
- Jan 2017
- Primary completion
- Dec 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of gabapentin, orphenadrine, acetaminophen, lidocaine, bupivacaine and 4 more in postoperative pain and postoperative ileus (POI) (2 arms), sponsored by University of Illinois College of Medicine Peoria. Primary endpoints: Length of Hospital Stay at 30 days, Days to Return of Bowel Function at 30 days and 2 more. Status: unknown.
02
Drugs
gabapentinorphenadrineacetaminophenlidocainebupivacaine
03
Conditions
postoperative painpostoperative ileus (POI)
Beyond the preview
Go deeper on NCT02958566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02958566.